HEMPCO®
Human Double-Blind Clinical Studies
Weight Loss
|
After 90 days |
|
| Average weight loss |
10.2 pounds |
Up to 22 pounds |
| Average girth loss |
2.22 inches |
Up to 6 inches |
| Average BMI decrease |
3.0 points |
Up to 8 points |
Bloodwork Results
|
After 90 days |
| HBA1c |
Average decrease 4.92% |
| Homocysteine |
Average decrease 11.47% |
| ||-1 |
Average decrease 42.11% |
| ||-6 |
Average decrease 32.91% |
| CRP |
Average decrease 8.98% |
| WBC |
Average increase 3.43% |
Sleep
|
After 90 days |
|
|
| Deep Sleep |
174 min > placebo |
2.9 hours > placebo |
185.35% > placebo |
| Awake Time |
22.64 min < placebo |
65.93% < placebo |
|
| Calories Burned |
4.10% average |
|
|
Anxiety Reported
|
After 90 days |
| Less fear |
80% |
| Less nervous |
68% |
| Less anxiety |
69% |
| Less worrying |
54% |
| Less over-worrying |
81% |
| More able to relax |
88% |
Cravings Reported
|
After 90 days |
| Less hungry |
99% |
| Less craving food |
94% |
| Less craving sweet food |
99% |
| Less craving savory food |
99% |
| Easier to resist cravings |
99% |
Pain Reported
|
After 90 days |
| Less pain |
64% |
| Less pain during activity |
82% |
| Less pain during walking |
61% |
| Less pain outside work |
91% |
| Less pain during sleep |
99% |
BACK TO CLINICAL STUDIES PAGE